Piramal Pharma Targets Peptide APIs Market, Acquires 100% Stake in India’s API Manufacturer Hemmo
India’s Piramal Pharma Solutions (PPS), a Contract Development and Manufacturing Organization (CDMO) of Piramal Pharma Limited, announced the full acquisition of Hemmo Pharmaceuticals, one of India’s largest synthetic peptides manufacturers. …
Read More